Inventor · disambiguated record
Emily M. Stocking
Also filed as: STOCKING EMILY M
21 granted patents·13 pending applications·61 citations·filing 2005–2024
93Inventor score
Files withNEUROPORE THERAPIES INC14JANSSEN PHARMACEUTICA NV9ALLISON BRETT2CARRUTHERS NICHOLAS I2KEITH JOHN M2
Top patents by PatentIndex Score
34 records- 0194US11667644B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Jun 6, 2023·2 cites·31 claims
- 0292US12049462B2Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathwaysNEUROPORE THERAPIES INC·Filed 2022·Granted Jul 30, 2024·1 cites·34 claims
- 0392US9079911B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jul 14, 2015·13 cites·17 claims
- 0492US8653263B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsCHAI WENYING·Filed 2010·Granted Feb 18, 2014·24 cites·30 claims
- 0589US11492348B2Tri-substituted aryl and heteroaryl derivatives as modulators of PI3-kinase and autophagy pathwaysNEUROPORE THERAPIES INC·Filed 2019·Granted Nov 8, 2022·3 cites·17 claims
- 0689US11008294B2Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2019·Granted May 18, 2021·3 cites·22 claims
- 0788US12378254B2Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Aug 5, 2025·0 cites·13 claims
- 0887US11059828B2Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Jul 13, 2021·3 cites·21 claims
- 0987US10501423B2Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2019·Granted Dec 10, 2019·3 cites·23 claims
- 1086US11708338B2Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2021·Granted Jul 25, 2023·1 cites·24 claims
- 1185USRE48841EDisubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2010·Granted Dec 7, 2021·2 cites·37 claims
- 1281US2024327396A1Tri-substituted aryl and heteroaryl derivatives as modulators of pi3-kinase and autophagy pathwaysNEUROPORE THERAPIES INC·Filed 2024·Application pending·0 cites
- 1379US2023391734A1Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofNEUROPORE THERAPIES INC·Filed 2023·Application pending·0 cites
- 1478US8883776B2Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine H3 receptorLETAVIC MICHAEL A·Filed 2008·Granted Nov 11, 2014·4 cites·16 claims
- 1577US10358443B2Heteroaryl amides as inhibitors of protein aggregationUCB BIOPHARMA SPRL·Filed 2017·Granted Jul 23, 2019·1 cites·4 claims
- 1675US11236079B2Morpholine derivates as inhibitors of Vps34NEUROPORE THERAPIES INC·Filed 2019·Granted Feb 1, 2022·1 cites·34 claims
- 1772US2022298155A1Compounds and compositions as modulators of tlr signalingNEUROPORE THERAPIES INC·Filed 2022·Application pending·0 cites
- 1869US11078196B2Heteroaryl amides as inhibitors of protein aggregationUCB Biopharma SRL·Filed 2019·Granted Aug 3, 2021·0 cites·37 claims
- 1963US2017129901A1Disubstituted Octahydropyrrolo[3,4-C]Pyrroles As Orexin Receptor ModulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Application pending·0 cites
- 2061US11299487B2Compounds and compositions as modulators of TLR signalingNEUROPORE THERAPIES INC·Filed 2020·Granted Apr 12, 2022·0 cites·8 claims
- 2158US2015335651A1DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2015·Application pending·0 cites
- 2256US9738635B2Heteroaryl amides as inhibitors of protein aggregationNEUROPORE THERAPIES INC·Filed 2015·Granted Aug 22, 2017·0 cites·6 claims
- 2356US7767666B2Butyl and butynyl benzyl amine compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Aug 3, 2010·0 cites·39 claims
- 2456US2024043395A1Compounds and compositions as modulators of tlr signalingNEUROPORE THERAPIES INC·Filed 2021·Application pending·0 cites
- 2555US2009137562A1Substituted benzyl amine compoundsALLISON BRETT·Filed 2008·Application pending·0 cites
- 2653US7479493B2Substituted benzyl amine compoundsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jan 20, 2009·0 cites·31 claims
- 2751US8236792B2Substituted pyrrolidine amides as modulators of the histamine H3 receptorCARRUTHERS NICHOLAS I·Filed 2009·Granted Aug 7, 2012·0 cites·40 claims
- 2846US2008045508A1Substituted aminomethyl benzamide compoundsALLISON BRETT·Filed 2007·Application pending·0 cites
- 2943US2015197513A1Aryl- and heteroaryl-substituted benzene derivatives as modulators of pi3-kinase signalling pathwaysNEUROPORE THERAPIES INC·Filed 2013·Application pending·0 cites
- 3042US2008139564A1Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulatorsKEITH JOHN M·Filed 2007·Application pending·0 cites
- 3141US10975066B2Bis-heteroaryl derivatives as modulators of protein aggregationUCB Biopharma SRL·Filed 2016·Granted Apr 13, 2021·0 cites·21 claims
- 3241US2010256122A1Butyl and butynyl benzyl amine compoundsKEITH JOHN M·Filed 2010·Application pending·0 cites
- 3341US2021290597A1Method of treating a condition associated with neurodegeneration using inhibitors of oat3NEUROPORE THERAPIES INC·Filed 2019·Application pending·0 cites
- 3439US2006194837A1Tetrahydroisoquinoline compoundsCARRUTHERS NICHOLAS I·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Emily M. Stocking files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →